| Upcoming events on GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED |
|
| 03/19/21 | | FY 2020 Earnings Release |
| 04/23/21 | | Q1 2021 Earnings Release (Projected) |
| 08/13/21 | | Interim 2021 Earnings Release (Projected) |
| 11/03/21 | | Q3 2021 Earnings Release (Projected) |
|
| Past events on GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED |
|
| 11/22/20 | 09:00pm | | Extraordinary Shareholders Meeting |
| 10/29/20 | | Q3 2020 Earnings Release |
| 08/27/20 | 10:00pm | | Extraordinary Shareholders Meeting |
| 08/25/20 | | Interim 2020 Earnings Release |
|
| Upcoming sector events for GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED |
|
|
| |
|
| Past sector events for GUANGZHOU BAIYUNSHAN PHARMACEUTICAL HOLDINGS COMPANY LIMITED |
|
|
|
|
|
| Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales
M CNY |
Released
Forecast
Spread | 19 125
19 902
-3,9% | 20 036
20 174
-0,68% | 20 954
20 567
1,9% | 42 234
43 424
-2,7% | 64 952
63 519
2,3% |
63 998
|
Operating income
(EBITDA)
M CNY |
Released
Forecast
Spread | 1 628
1 498
8,7% | 1 710
1 416
21% | 2 716
1 807
50% | 4 169
3 693
13% | 4 681
4 783
-2,1% |
5 100
|
Operating profit
(EBIT)
M CNY |
Released
Forecast
Spread | 1 410
1 387
1,7% | 1 467
1 233
19% | 2 461
1 725
43% | 3 836
3 664
4,7% | 4 055
4 144
-2,2% |
4 350
|
Pre-Tax Profit
(EBT)
M CNY |
Released
Forecast
Spread | 1 628
1 495
8,9% | 1 945
1 753
11% | 2 493
2 269
9,9% | 4 019
4 719
-15% | 4 129
4 330
-4,7% |
4 445
|
Net income
M CNY |
Released
Forecast
Spread | 1 300
1 364
-4,7% | 1 508
1 398
7,9% | 2 062
1 846
12% | 3 441
3 144
9,5% | 3 189
3 469
-8,1% |
3 394
|
EPS
CNY |
Released
Forecast
Spread | 1,01
1,04
-3,6% | 1,08
0,98
10% | 1,27
1,10
15% | 2,12
1,50
41% | 1,96
2,14
-8,2% |
2,07
| | Announcement Date | 03/18/2016 | 03/15/2017 | 03/15/2018 | 03/17/2019 | 03/31/2020 | |
|
|
|
| Quarterly results | 2015 S2 | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 |
Sales
M CNY |
Released
Forecast
Spread | 8 653
9 420
-8,1% | 7 931
14 632
-46% | 15 036
15 147
-0,74% | 12 358
15 147
-18% | 18 055
10 132
78% | 15 286
11 750
30% | 16 722
22 618
-26% | 14 889
11 209
33% | 16 985
18 354
-7,5% | 13 485
16 229
-17% | 16 415
18 728
-12% |
Operating income
(EBITDA)
M CNY |
Released
Forecast
Spread |
|
118
|
696
|
696
|
1 553
|
1 422
|
|
144
|
2 269
|
|
|
Operating profit
(EBIT)
M CNY |
Released
Forecast
Spread | 453
734
-38% | 1 856
47,0
3 851% | 826
625
32% | 27,9
625
-96% | 1 770
1 468
21% | 1 407
1 336
5,3% |
| 87,0
58,0
50% | 1 516
2 178
-30% |
|
|
Pre-Tax Profit
(EBT)
M CNY |
Released
Forecast
Spread | 665
830
-20% | 1 868
185
907% | 970
784
24% | 38,0
784
-95% | 1 774
1 478
20% | 1 438
1 534
-6,3% |
| 77,5
41,8
85% | 1 520
2 245
-32% |
|
|
Net income
M CNY |
Released
Forecast
Spread | 525
650
-19% | 1 714
-21,7
7 981% | 820
576
42% | 1,69
| 1 407
1 172
20% | 1 141
1 275
-11% |
| 29,4
99,1
-70% | 1 184
1 847
-36% |
|
|
EPS
CNY |
Released
Forecast
Spread |
| 1,05
-0,01
7 977% | 0,51
0,35
44% | 0,00
| 0,87
0,72
20% | 0,70
0,78
-10% | 0,39
| 0,02
0,06
-70% | 0,73
1,02
-29% | 0,36
0,72
-50% | 0,55
0,60
-8,2% | | Announcement Date | 03/18/2016 | 08/22/2018 | 10/29/2018 | 03/17/2019 | 04/28/2019 | 08/22/2019 | 10/28/2019 | 03/31/2020 | 04/28/2020 | 08/25/2020 | 10/28/2020 |
|
Financial data source
© 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
Previous period
